Cabaletta Bio, Inc. (CABA)
$1.69-5.59%Close
SELLCRISIS · day 25
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $276M
- Beta
- 3.48
- P/E (TTM)
- -1.07
- Short % float
- 27.02%
- Days to cover
- 6.3
- SI change
- +15.9%
- 1W
- -16.34%
- 1M
- -41.92%
- vs SPY 1W
- -16.20%
- vs SPY 1M
- -44.43%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CABA?
- LOPJLB’s latest quantitative signal on Cabaletta Bio, Inc. (CABA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is CABA in?
- Cabaletta Bio, Inc. (CABA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Cabaletta Bio, Inc. (CABA) do?
- Cabaletta Bio, Inc. is a biotechnology firm in the clinical development stage, specializing in the invention and advancement of sophisticated engineered T cell therapies. Its core mission is to treat autoimmune diseases where B cells are implicated in producing harmful autoantibodies. The company's unique chimeric autoantibody receptor (CAAR) T cell platform is engineered to precisely target an…